Clinical trial
Efficacy of Lecanemab in Patients With Parkinson's Disease With Coexistent Alzheimer's Disease
NCT07544953 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Lecanemab in Patients With Parkinson's Disease With Coexistent Alzheimer's Disease
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- November 30, 2030
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.